<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Xiao Y</submitter><funding>National Natural Science Foundation</funding><pagination>1928-1940</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7469443</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>19(15)</volume><pubmed_abstract>Psoriasis is an immune-mediated chronic inflammatory skin disease. Keratinocyte hyperproliferation has been regarded as a significant event in psoriasis pathogenesis. Considering the vital role of miRNA-mediated mRNA repression in psoriasis pathogenesis, in the present study, we attempted to investigate the mechanism of keratinocyte overproliferation from the point of miRNA-mRNA regulation. Both online microarray expression profiles and experimental results indicated that the expression of LXR-α and PPAR-γ was downregulated in psoriasis lesion skin. LXR-α or PPAR-γ overexpression alone was sufficient to inhibit keratinocyte proliferation, decrease KRT5 and KRT14 protein levels and increase KRT1 and KRT10 protein levels. miR-203 negatively regulated LXR-α and PPAR-γ expression through direct targeting. miR-203 inhibition exerted the opposite effects to LXR-α or PPAR-γ overexpression on HaCaT cells. More importantly, LXR-α or PPAR-γ overexpression could markedly remarkably attenuate the effects of miR-203 overexpression in keratinocytes, indicating that miR-203 promotes keratinocyte proliferation by targeting LXR-α and PPAR-γ. In conclusion, the miR-203-LXR-α/PPAR-γ axis modulates the proliferation of keratinocytes and might be a novel target for psoriasis treatment, which needs further in vivo investigation.</pubmed_abstract><journal>Cell cycle (Georgetown, Tex.)</journal><pubmed_title>miR-203 promotes HaCaT cell overproliferation through targeting LXR-α and PPAR-γ.</pubmed_title><pmcid>PMC7469443</pmcid><funding_grant_id>81573985</funding_grant_id><pubmed_authors>Zeng B</pubmed_authors><pubmed_authors>Peng Y</pubmed_authors><pubmed_authors>Yang Z</pubmed_authors><pubmed_authors>Wang C</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Luo M</pubmed_authors><pubmed_authors>Xiao Y</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Tang X</pubmed_authors><pubmed_authors>Huang P</pubmed_authors></additional><is_claimable>false</is_claimable><name>miR-203 promotes HaCaT cell overproliferation through targeting LXR-α and PPAR-γ.</name><description>Psoriasis is an immune-mediated chronic inflammatory skin disease. Keratinocyte hyperproliferation has been regarded as a significant event in psoriasis pathogenesis. Considering the vital role of miRNA-mediated mRNA repression in psoriasis pathogenesis, in the present study, we attempted to investigate the mechanism of keratinocyte overproliferation from the point of miRNA-mRNA regulation. Both online microarray expression profiles and experimental results indicated that the expression of LXR-α and PPAR-γ was downregulated in psoriasis lesion skin. LXR-α or PPAR-γ overexpression alone was sufficient to inhibit keratinocyte proliferation, decrease KRT5 and KRT14 protein levels and increase KRT1 and KRT10 protein levels. miR-203 negatively regulated LXR-α and PPAR-γ expression through direct targeting. miR-203 inhibition exerted the opposite effects to LXR-α or PPAR-γ overexpression on HaCaT cells. More importantly, LXR-α or PPAR-γ overexpression could markedly remarkably attenuate the effects of miR-203 overexpression in keratinocytes, indicating that miR-203 promotes keratinocyte proliferation by targeting LXR-α and PPAR-γ. In conclusion, the miR-203-LXR-α/PPAR-γ axis modulates the proliferation of keratinocytes and might be a novel target for psoriasis treatment, which needs further in vivo investigation.</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Aug</publication><modification>2024-02-15T01:49:49.682Z</modification><creation>2022-02-10T16:41:49.804Z</creation></dates><accession>S-EPMC7469443</accession><cross_references><pubmed>32594829</pubmed><doi>10.1080/15384101.2020.1783934</doi></cross_references></HashMap>